<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="nijmegen" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">nijmegen</book-part-id>
      <title-group>
        <title>Nijmegen Breakage Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varon</surname>
            <given-names>Raymonda</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Institute of Medical and Human Genetics<break/>Charit&#x000e9; &#x02013; Universit&#x000e4;tsmedizin Berlin<break/>Berlin, Germany</aff>
          <email>raymonda.varon-mateeva@charite.de</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Demuth</surname>
            <given-names>Ilja</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Institute of Medical and Human Genetics<break/>Charit&#x000e9; &#x02013; Universit&#x000e4;tsmedizin Berlin<break/>Berlin, Germany</aff>
          <email>Ilja.demuth@charite.de</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chrzanowska</surname>
            <given-names>Krystyna H</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>The Children&#x02019;s Memorial Health Institute<break/>Warsaw, Poland</aff>
          <email>k.chrzanowska@ipczd.pl</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>17</day>
          <month>5</month>
          <year>1999</year>
        </date>
        <date date-type="updated">
          <day>2</day>
          <month>2</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="npc" document-type="chapter">Niemann-Pick Disease Type C</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="xxms" document-type="chapter">Nonsyndromic 46,XX Testicular Disorders of Sex Development</related-object>
      <abstract id="nijmegen.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Nijmegen breakage syndrome (NBS) is characterized by progressive microcephaly, intrauterine growth retardation and short stature, recurrent sinopulmonary infections, an increased risk for cancer, and premature ovarian failure in females. Developmental milestones are attained at the usual time during the first year; however, borderline delays in development and hyperactivity may be observed in early childhood. Intellectual abilities tend to decline over time and most children tested after age seven years have mild to moderate intellectual disability. Recurrent pneumonia and bronchitis may result in respiratory failure and early death. Approximately 40% of affected individuals have developed malignancies before age 20 years, with the risk being highest for T-cell (55%) and B-cell lymphomas (45%). Other tumors include solid tumors (e.g., medulloblastoma, glioma, and rhabdomyosarcoma). Note, however, that much of what is reported about NBS is based on individuals who are homozygous for the single most common Eastern European pathogenic variant, c.657_661del5.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of NBS is established in a proband with the clinical findings listed above who has biallelic pathogenic variants in <italic toggle="yes">NBN</italic> on molecular genetic testing and/or absent nibrin protein on immunoblotting assay.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Vitamin E and folic acid supplementation; use of IVIg in individuals with severe humoral immunodeficiency and frequent infections; standard chemotherapy protocols for lymphoid malignancies (adopted to individual tolerance); consideration of hematopoietic stem cell transplantation; hormone replacement therapy for females who have hypergonadotropic hypogonadism.</p>
          <p>
            <italic toggle="yes">Surveillance:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>For affected individuals: Periodic follow up to monitor developmental progress, physical growth and infection frequency; in those with weight loss, assessment for malignancy should be considered; lifelong monitoring of immune biomarkers; careful monitoring by an oncologist; monitoring for pubertal progression in both sexes and premature ovarian insufficiency in females; breast self-examination and ultrasonographic evaluation.</p>
            </list-item>
            <list-item>
              <p>For carriers (heterozygotes): Parents should be monitored for malignancy, particularly breast cancer in women and prostate cancer in men.</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Because the cells from individuals with NBS are radiosensitive in vitro, doses of radiation used in radiotherapy need to be reduced. Unnecessary exposure to imaging studies that use ionizing radiation (plain radiograph, CT scan) should be avoided and use of MRI and/or ultrasound considered.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: Molecular genetic testing for the <italic toggle="yes">NBN</italic> pathogenic variants identified in the proband should be offered to apparently asymptomatic sibs of a proband and young adult relatives at risk of being carriers (heterozygotes) in order to identify as early as possible those who would benefit from monitoring for malignancy and to inform treatment options if a malignancy is diagnosed.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>NBS is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing are possible if both of the pathogenic variants have been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="nijmegen.Diagnosis">
        <title>Diagnosis</title>
        <sec id="nijmegen.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Nijmegen breakage syndrome (NBS) <bold>should be suspected</bold> in individuals with the following clinical and supportive laboratory findings.</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Disproportionate microcephaly</bold> that is progressive</p>
            </list-item>
            <list-item>
              <p><bold>Craniofacial features</bold> that include a sloping forehead, upward slanted palpebral fissures, prominent nose, relatively large ears, and retrognathia</p>
            </list-item>
            <list-item>
              <p><bold>Growth retardation</bold> that is more pronounced from birth until the age of three years, with mild improvement thereafter</p>
            </list-item>
            <list-item>
              <p><bold>Recurrent infections</bold> including pneumonia, bronchitis, sinusitis, otitis media, and mastoiditis</p>
            </list-item>
            <list-item>
              <p><bold>Malignancies,</bold> predominantly of lymphoid origin</p>
            </list-item>
            <list-item>
              <p><bold>Decline in intellectual ability,</bold> from normal or borderline-normal during early childhood to moderate intellectual disability in older individuals</p>
            </list-item>
          </list>
          <p>
            <bold>Supportive laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Immunodeficiency</bold> involving the humoral and cellular systems [<xref ref-type="bibr" rid="nijmegen.REF.gregorek.2002.319">Gregorek et al 2002</xref>, <xref ref-type="bibr" rid="nijmegen.REF.micha_kiewicz.2003.482">Micha&#x00142;kiewicz et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.wolskaku_nierz.2015.538">Wolska-Ku&#x0015b;nierz et al 2015</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Severe hypogammaglobulinemia has been found in 20%-24% of affected individuals and IgA deficiency in 50%-57%.</p>
                </list-item>
                <list-item>
                  <p>Deficiencies of IgG2 and IgG4 are frequent even when the IgG serum concentration is normal.</p>
                </list-item>
                <list-item>
                  <p>The most commonly reported defects in cellular immunity include reduced absolute numbers of total B cells, CD3+ T cells, and CD4+ cells; observed in 80%-89% of affected individuals.</p>
                </list-item>
                <list-item>
                  <p>An increased frequency of T cells with a memory phenotype (CD45RO+) and a concomitant decrease in na&#x000ef;ve T cells (CD45RA+) has been reported.</p>
                </list-item>
                <list-item>
                  <p>The in vitro proliferation of T and B lymphocytes to antigen and/or mitogenic stimuli is greatly reduced in most affected individuals.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>
                <bold>Chromosome instability</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Inversions and translocations involving chromosomes 7 and 14 are observed in PHA-stimulated lymphocytes in 10%-50% of metaphases.</p>
                </list-item>
                <list-item>
                  <p>The breakpoints most commonly involved are 7p13, 7q35, 14q11, and 14q32, which are the loci for immunoglobulin and T cell-receptor genes.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Radiation sensitivity.</bold> Cells from individuals with NBS have a decrease in colony-forming ability following exposure to ionizing radiation and radiomimetics in vitro.</p>
              <p>Note: This test requires that a lymphoblastoid cell line be established. Because this process is more commonly performed in a research lab than in a clinical lab, the test may not be widely available clinically.</p>
            </list-item>
          </list>
        </sec>
        <sec id="nijmegen.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of NBS <bold>is established</bold> in a proband with the <xref ref-type="sec" rid="nijmegen.Suggestive_Findings">clinical features</xref> listed above who has biallelic pathogenic variants in <italic toggle="yes">NBN</italic> on molecular genetic testing (see <xref ref-type="table" rid="nijmegen.T.molecular_genetic_testing_use">Table 1</xref>) and/or absent nibrin protein on an immunoblotting assay (see <bold>Immunoblotting</bold>; below <xref ref-type="table" rid="nijmegen.T.molecular_genetic_testing_use">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <p>
            <bold>Single-gene testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Targeted analysis for the pathogenic variant c.657_661del5 can be performed first. The c.657_661del5 pathogenic variant is detected in:</p>
              <list list-type="bullet">
                <list-item>
                  <p>~100% of alleles in individuals of Slavic (Poland, Czech Republic, Ukraine) ancestry;</p>
                </list-item>
                <list-item>
                  <p>~70% of alleles in individuals of North American ancestry.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the common allele is not present in a homozygous form, sequence analysis of <italic toggle="yes">NBN</italic> can be pursued.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">NBN</italic> and other genes of interest (see <xref ref-type="sec" rid="nijmegen.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
          <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <table-wrap id="nijmegen.T.molecular_genetic_testing_use" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Nijmegen Breakage Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">NBN</italic>
                  </td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for the c.657_661del5 variant&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">70-100%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_nijmegen.T.molecular_genetic_testing_use_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="nijmegen.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="nijmegen" object-id="nijmegen.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="nijmegen.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="nijmegen.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="nijmegen.TF.1.3">
                <label>3. </label>
                <p>Methods that may be used to detect the <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.657_661del5</xref> pathogenic variant can include: allele-specific PCR, sequence analysis, and genotyping assays designed to this variant. Note that these assays may not detect variants other than the targeted variant.</p>
              </fn>
              <fn id="nijmegen.TF.1.4">
                <label>4. </label>
                <p>Nearly all affected individuals from Poland, the Czech Republic, and Ukraine tested to date are homozygous for the common pathogenic variant <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.657_661del5</xref>. In a study of eight unrelated individuals with NBS from the Russian population, <xref ref-type="bibr" rid="nijmegen.REF.resnick.2002.355">Resnick et al [2002]</xref> found that all but one of the 16 alleles were c.657_661del5. In the US, about 70% of individuals tested to date are homozygous for the common allele, 15% are heterozygous for c.657_661del5 and a second unique pathogenic variant, and 15% are homozygous for a unique pathogenic variant. In the US patient population, almost all affected individuals who have the <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.657_661del5</xref> pathogenic variant are of known Eastern European ancestry.</p>
              </fn>
              <fn id="nijmegen.TF.1.5">
                <label>5. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="nijmegen.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="nijmegen.TF.1.7">
                <label>7. </label>
                <p>No deletions or duplications involving this gene have been reported to cause NBS.</p>
              </fn>
              <fn id="nijmegen.TF.1.8">
                <label>8. </label>
                <p><italic toggle="yes">NBN</italic> is the only gene associated with NBS; however, because NBS is clinically similar to other disorders (see <xref ref-type="sec" rid="nijmegen.Differential_Diagnosis">Differential Diagnosis</xref>), many individuals referred for diagnostic testing for NBS based on clinical findings and radiosensitivity lack identified pathogenic variants in <italic toggle="yes">NBN</italic> [Author, unpublished observation]. Presently, distinction can only be made by excluding pathogenic variants in <italic toggle="yes">NBN</italic>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Immunoblotting</bold> can be used to determine if the nibrin protein is present or absent.</p>
          <p>Note: This test requires that a lymphoblastoid cell line be established. Because this process is more commonly performed in a research lab than in a clinical lab, the test may not be widely available clinically.</p>
        </sec>
      </sec>
      <sec id="nijmegen.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="nijmegen.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Growth.</bold> Children with Nijmegen breakage syndrome (NBS) generally are born with weight below normal for gestational age and microcephaly (i.e., head circumference &#x0003e;2 SD below the mean for age and gender). Microcephaly progresses with age &#x02013; in contrast to linear growth, which may improve with age, causing disproportionate head dimensions compared to the rest of the body. Microcephaly is occasionally masked by hydrocephaly or developmental abnormalities of the brain [Szcza&#x00142;uba 2012].</p>
          <p>Growth failure in the early stages of life results in length/height that is usually below the third centile by age two years. Thereafter, linear growth velocity tends to normalize, however many individuals remain shorter than peers (i.e., affected individuals do not experience catch-up growth). Some adults, both females and males, can achieve height within lower normal ranges [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2012.13">Chrzanowska et al 2012</xref>].</p>
          <p><bold>Craniofacial features.</bold> The craniofacial features discussed in <xref ref-type="sec" rid="nijmegen.Suggestive_Findings">Suggestive Findings</xref> are found in the majority of affected individuals and become more pronounced with age as microcephaly progresses.</p>
          <p><bold>Infections.</bold> Respiratory infections are the most common. Recurrent pneumonia and bronchitis may result in bronchiectasis, and even in pulmonary failure and early death. Chronic diarrhea and urinary tract infections may also occur.</p>
          <p><bold>Malignancy.</bold> According to <xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2012.13">Chrzanowska et al [2012]</xref>, 40% of affected individuals reported to date have developed malignancies before age 20 years. Malignancies are primarily lymphomas [<xref ref-type="bibr" rid="nijmegen.REF.g_adkowskadura.2008.337">G&#x00142;adkowska-Dura et al 2008</xref>, <xref ref-type="bibr" rid="nijmegen.REF.wolskaku_nierz.2015.538">Wolska-Ku&#x0015b;nierz et al 2015</xref>]. Approximately 45% of lymphomas are of B cell origin and 55% are T cell lymphomas. Several children have developed solid tumors, including medulloblastomas, glioma, and rhabdomyosarcoma [<xref ref-type="bibr" rid="nijmegen.REF.hiel.2001.e19">Hiel et al 2001</xref>, <xref ref-type="bibr" rid="nijmegen.REF.bakhshi.2003.248">Bakhshi et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.distel.2003.44">Distel et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.meyer.2004.169">Meyer et al 2004</xref>].</p>
          <p><bold>Psychomotor and intellectual development.</bold> Developmental milestones are attained at the usual time during the first year. Normal or borderline intellectual development and psychomotor hyperactivity may be observed in early childhood/pre-school age. Intellectual abilities tend to decline from mild to moderate intellectual disability during childhood. Affected children are described as having a cheerful, shy personality with good interpersonal skills.</p>
          <p><bold>Fertility.</bold> Two reports of gonadal dysfunction in affected females with chromosome instability disorder / syndrome appeared in 1986 [<xref ref-type="bibr" rid="nijmegen.REF.maraschio.1986.353">Maraschio et al 1986</xref>]. Twenty years later, <xref ref-type="bibr" rid="nijmegen.REF.varon.2006.679">Varon et al [2006]</xref> identified biallelic pathogenic <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.741_742dup</xref> variants in exon 7 of <italic toggle="yes">NBN</italic> one of the original women reported by <xref ref-type="bibr" rid="nijmegen.REF.maraschio.1986.353">Maraschio and colleagues [1986]</xref>.</p>
          <p><xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2000.s73">Chrzanowska et al [2000]</xref> originally presented observations that strongly suggested an increased risk of premature ovarian failure in women with NBS. Results of a longitudinal study demonstrated that hypergonadotropic hypogonadism was present in a large cohort of affected females, all of whom were homozygous for the common <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.657_661del5</xref> pathogenic variant [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2010a.3133">Chrzanowska et al 2010a</xref>].</p>
          <p>No detailed studies of fertility in males with NBS have been published; however, puberty initiation and progress are comparable to healthy boys [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2010b.88">Chrzanowska et al 2010b</xref>]. <xref ref-type="bibr" rid="nijmegen.REF.warcoin.2009.424">Warcoin et al [2009]</xref> described two adult siblings, a male with oligo-terato-asthenozoospermia and a female with premature ovarian failure, who had biallelic truncating variants in <italic toggle="yes">NBN</italic> but none of the other clinical features of NBS.</p>
          <p>
            <bold>Other findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Irregular skin pigmentation in the form of irregular hyperpigmented or hypopigmented macules is seen in most affected individuals. In some affected individuals, progressive sarcoid-like granulomas are observed [<xref ref-type="bibr" rid="nijmegen.REF.yoo.2008.418">Yoo et al 2008</xref>, <xref ref-type="bibr" rid="nijmegen.REF.pasic.2012.138">Pasic et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Congenital malformations, usually observed in single cases, include anomalies of the central nervous system (e.g., hydrocephaly, schizencephaly, arachnoid cysts), choanal atresia, cleft lip and palate, tracheal hypoplasia, preaxial or postaxial polydactyly, horseshoe kidney, hydronephrosis, hypospadias, anal stenosis/atresia, and congenital hip dysplasia.</p>
            </list-item>
          </list>
          <p><bold>Heterozygotes.</bold> Heterozygotes are asymptomatic, however, there is clear evidence of increased cancer occurrence among heterozygous relatives of individuals with NBS in the Czech Republic [<xref ref-type="bibr" rid="nijmegen.REF.seemanov_.2007.1875">Seemanov&#x000e1; et al 2007</xref>]. Furthermore, an increased frequency of the pathogenic <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.657_661del5</xref> variant in <italic toggle="yes">NBN</italic> has been observed in several different cancers including breast cancer, prostate cancer, medulloblastoma, and melanoma, suggesting that pathogenic variants in <italic toggle="yes">NBN</italic> might play a role in the etiology of these types of cancer [<xref ref-type="bibr" rid="nijmegen.REF.cybulski.2004.1215">Cybulski et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.steffen.2004.67">Steffen et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.ciara.2010.325">Ciara et al 2010</xref>].</p>
        </sec>
        <sec id="nijmegen.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The common pathogenic variant, c.657_661del5, and most other loss-of-function variants result in a classic presentation. However, exceptions have been reported. There are two reports of families in which biallelic truncating variants in <italic toggle="yes">NBN</italic> occur in individuals with milder features:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="nijmegen.REF.varon.2006.679">Varon et al [2006]</xref> described a 53-year-old woman who was homozygous for the <italic toggle="yes">NBN</italic> truncating allele <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.741_742dupGG</xref>. This affected woman had a somewhat milder phenotype including microcephaly, chromosome instability, immunodeficiency, and primary amenorrhea. Her sister, with similar clinical manifestations died at 20 years of malignant lymphoma [<xref ref-type="bibr" rid="nijmegen.REF.maraschio.1986.353">Maraschio et al 1986</xref>]. However, analysis of transcripts from the affected individual&#x02019;s cells indicated a highly prevalent alternatively spliced form of <italic toggle="yes">NBN</italic> lacking exons 6 and 7 (where the pathogenic variant is located). This transcript produces a 73-kd form of NBN with an internal deletion.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="nijmegen.REF.warcoin.2009.424">Warcoin et al [2009]</xref> described a family in which two healthy adult sibs, a sister and a brother, had biallelic truncating variants in <italic toggle="yes">NBN</italic> (p.Tyr110Ter and <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">p.Trp375Ter</xref>). Both were normal on clinical examination and did not have any evidence of short stature, reduced head circumference, or facial dysmorphic features; however, both were referred for fertility defects and were subsequently found to have the cellular phenotypes typical of NBS including chromosome instability, hypersensitivity to ionizing radiation, and impaired checkpoint responses.</p>
            </list-item>
          </list>
        </sec>
        <sec id="nijmegen.Nomenclature">
          <title>Nomenclature</title>
          <p>The Nijmegen breakage syndrome was described by <xref ref-type="bibr" rid="nijmegen.REF.weemaes.1981.557">Weemaes et al [1981]</xref>.</p>
          <p>Three Czech families with Seemanov&#x000e1; syndrome [<xref ref-type="bibr" rid="nijmegen.REF.seemanov_.1985.639">Seemanov&#x000e1; et al 1985</xref>] were later identified as having NBS.</p>
          <p>Genetic complementation studies are no longer of clinical importance. The report of <xref ref-type="bibr" rid="nijmegen.REF.jaspers.1988.259">Jaspers et al [1988]</xref> noted a strong similarity between NBS cells and <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object> (A-T) cells; however, they also described the NBS cells as genetically distinct from A-T, grouping individuals with either Nijmegen breakage syndrome or Czech breakage syndrome into A-T variant group V1 and Germans with 'Berlin breakage syndrome' [<xref ref-type="bibr" rid="nijmegen.REF.wegner.1999">Wegner et al 1999</xref>] into A-T variant group V2 [<xref ref-type="bibr" rid="nijmegen.REF.jaspers.1988.259">Jaspers et al 1988</xref>]. Subsequently, <italic toggle="yes">NBN</italic> pathogenic variants were found in all individuals studied from the A-T variant groups V1 and V2, indicating that these individuals had NBS, not ataxia-telangiectasia.</p>
        </sec>
        <sec id="nijmegen.Prevalence">
          <title>Prevalence</title>
          <p>No reliable estimates of world-wide prevalence exist, but it is likely to approximate 1:100,000 live births.</p>
          <p>NBS is most common in Eastern European/Slavic populations. Studies in Poland, the Czech Republic, and the Ukraine have suggested that the carrier frequency of the common allele approaches 1:155 in these populations. The highest reported prevalence is in Sorbians, a Slavic population isolate from southeastern Germany, in whom the carrier frequency is estimated at 1:34 [<xref ref-type="bibr" rid="nijmegen.REF.maurer.2010.211">Maurer et al 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="nijmegen.Genetically_Related_Disorders">
        <title>Genetically Related Disorders</title>
        <p>Individuals homozygous for the <italic toggle="yes">NBN</italic>
<xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">c.1089C&#x0003e;A</xref> pathogenic variant have features of <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia</related-object> [<xref ref-type="bibr" rid="nijmegen.REF.gennery.2004.214">Gennery et al 2004</xref>].</p>
      </sec>
      <sec id="nijmegen.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Microcephaly, growth delay, immunodeficiency, and/or bone marrow failure are common manifestations of several inherited disorders, mainly related to defective sensing, processing, and repair of double-strand DNA breaks. Recurrent infections, poor growth, and immunodeficiency can be observed in other inherited immunodeficiencies. See <xref ref-type="table" rid="nijmegen.T.disorders_to_consider_in_the">Table 2</xref>.</p>
        <p>The early growth failure in Nijmegen breakage syndrome (NBS) may suggest other disorders of growth, such as thyroid hormone or growth hormone deficiency, or primary disorders of bone growth (i.e., skeletal dysplasias).</p>
        <p>Because malignancy may be the presenting finding in NBS, the diagnosis of NBS should be considered before radiotherapy is initiated in individuals with microcephaly who have solid tumors and are younger than age three years [<xref ref-type="bibr" rid="nijmegen.REF.bakhshi.2003.248">Bakhshi et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.distel.2003.44">Distel et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.meyer.2004.169">Meyer et al 2004</xref>].</p>
        <table-wrap id="nijmegen.T.disorders_to_consider_in_the" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of Nijmegen Breakage Syndrome</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Name</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene(s)</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Immunodeficiency and/or<break/>Bone Marrow Failure</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Microcephaly / Craniofacial Features</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Growth Delay</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cellular Sensitivity</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Chromosome Instability</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cancer Predisposition</th>
                <th id="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Nijmegen breakage syndrome</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">NBN</italic>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Immunodeficiency, combined; recurrent sinopulmonary infections</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Progressive disproportionate microcephaly&#x000a0;<sup>1</sup>; characteristic facial features&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Mild growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Decrease in colony-forming ability after exposure to ionizing radiation &#x00026; radiomimetics</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Inversions &#x00026; translocations involving chromosomes 7 &#x00026; 14 in lymphocytes</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Increased risk, mainly of lymphoid origin</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Primary ovarian failure; mild-to-moderate intellectual disability</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">LIG4</italic> syndrome&#x000a0;<sup>3</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606593">OMIM</ext-link></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">LIG4</italic>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Immunodeficiency combined; pancytopenia &#x00026; myelodysplastic syndrome</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly; facial features resembling NBS&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Short stature</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Severe radiosensitivity</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Increased chromosome breakage rate</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Predisposition to malignancy (mainly lymphoma &#x00026; leukemia)</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">High intrafamilial clinical variability</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">NHEJ1</italic> syndrome<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611291">OMIM</ext-link></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">NHEJ1</italic>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild immunodeficiency to severe combined immunodeficiency</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe (typically) growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Cellular sensitivity to ionizing radiation</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">High chromosome breakage rate (w/out chromosome 7;14 rearrangements)&#x000a0;<sup>4</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Limited data; unknown</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Short stature, microcephaly, and endocrine dysfunction&#x000a0;<italic toggle="yes"><sup>5</sup></italic><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/616541">OMIM</ext-link></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">XRCC4</italic>&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">No clinical manifestations of immunodeficiency</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Primary microcephaly</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Pronounced cellular radiosensitivity</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Not reported</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Solid tumor</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Primary ovarian failure; early-onset metabolic syndrome</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Nijmegen breakage syndrome-like disorder<break/>(RAD50 deficiency)&#x000a0;<sup>7,&#x000a0;8</sup><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613078">OMIM</ext-link></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">RAD50</italic>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">No immunodeficiency</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly; facial features resembling NBS&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">X-ray hypersensitivity</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Chromosome instability (incl. 7;14 rearrangements) in lymphocytes &#x00026; fibroblasts</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Limited data; unknown</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Normal puberty; disturbed sensorimotor coordination; intellectual disability</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia<sup>&#x000a0;</sup></related-object>
                  <sup>9</sup>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">18 genes&#x000a0;<sup>10</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Progressive bone marrow failure (pancytopenia); myelodysplastic syndrome</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly (1/3 of individuals)</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Cellular sensitivity to ionizing radiation &#x00026; DNA cross-linking agents&#x000a0;<sup>11</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Chromosome breakage induced by mitomycin C &#x00026; diepoxybutane</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Myeloblastic leukemia; solid tumors</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Limited fertility</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">Ataxia-telangiectasia</related-object>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ATM</italic> (A-T<sub>Fresno</sub>)&#x000a0;<sup>12</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">No increased risk of infections</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Hypersensitivity to ionizing radiation</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Chromosome instability (incl. 7;14 rearrangements) in lymphocytes</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Leukemia; Hodgkin &#x00026; non-Hodgkin lymphoma</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Scleral telangiectasia; progressive truncal ataxia; intellectual disability</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Seckel syndrome&#x000a0;<sup>13,&#x000a0;14</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 14</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Pancytopenia</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Severe microcephaly</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Severe growth restriction</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Not typically radiosensitive by colony survival assay&#x000a0;<sup>13</sup></td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Increased sister chromatid exchange</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Limited data, possible myelodyplasia</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Intellectual disability</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="rsts" document-type="chapter">Rubinstein-Taybi syndrome</related-object>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">CREBBP</italic>
                  <break/>
                  <italic toggle="yes">EP300</italic>
                </td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Recurrent infections; defect in polysaccharide antibody response</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Microcephaly; distinctive facial features</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Mild growth restriction; short stature</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">No cellular sensitivity</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_7" valign="middle" align="left" rowspan="1" colspan="1">Not present</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_8" valign="middle" align="left" rowspan="1" colspan="1">Leukemia; tumors that affect the head</td>
                <td headers="hd_h_nijmegen.T.disorders_to_consider_in_the_1_1_1_9" valign="middle" align="left" rowspan="1" colspan="1">Intellectual disability</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="nijmegen.TF.2.1">
              <label>1. </label>
              <p><xref ref-type="bibr" rid="nijmegen.REF.seeman.2004.195">Seeman et al [2004]</xref> suggest that <italic toggle="yes">NBN</italic> pathogenic variants account for a significant number of children with primary microcephaly in the Czech Republic.</p>
            </fn>
            <fn id="nijmegen.TF.2.2">
              <label>2. </label>
              <p>Facial features characteristic of Nijmegen breakage syndrome are: a sloping forehead, retrognathia, prominent nasal bridge and nose, large ears, and upslanted palpebral fissures.</p>
            </fn>
            <fn id="nijmegen.TF.2.3">
              <label>3. </label>
              <p><xref ref-type="bibr" rid="nijmegen.REF.odriscoll.2001.1175">O'Driscoll et al [2001]</xref>, <xref ref-type="bibr" rid="nijmegen.REF.benomran.2005.283">Ben-Omran et al [2005]</xref>, <xref ref-type="bibr" rid="nijmegen.REF.altmann.2016.137">Altmann &#x00026; Gennery [2016]</xref></p>
            </fn>
            <fn id="nijmegen.TF.2.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="nijmegen.REF.dutrannoy.2010.1059">Dutrannoy et al [2010]</xref>
              </p>
            </fn>
            <fn id="nijmegen.TF.2.5">
              <label>5. </label>
              <p><xref ref-type="bibr" rid="nijmegen.REF.murray.2015.412">Murray et al [2015]</xref>, <xref ref-type="bibr" rid="nijmegen.REF.rosin.2015.3708">Rosin et al [2015]</xref></p>
            </fn>
            <fn id="nijmegen.TF.2.6">
              <label>6. </label>
              <p>XRCC4 is another component of the non-homologous end joining (NHEJ) pathway.</p>
            </fn>
            <fn id="nijmegen.TF.2.7">
              <label>7. </label>
              <p>As only one individual with <italic toggle="yes">RAD50</italic> pathogenic variants has been described, it is unclear how consistent the clinical features of RAD50 deficiency appear to overlap with NBS.</p>
            </fn>
            <fn id="nijmegen.TF.2.8">
              <label>8. </label>
              <p><xref ref-type="bibr" rid="nijmegen.REF.barbi.1991.44">Barbi et al [1991]</xref>, <xref ref-type="bibr" rid="nijmegen.REF.waltes.2009.605">Waltes et al [2009]</xref></p>
            </fn>
            <fn id="nijmegen.TF.2.9">
              <label>9. </label>
              <p>Overlap of some clinical features and cellular sensitivity to ionizing radiation and DNA cross-linking agents could lead to misdiagnosis of NBS as Fanconi anemia [<xref ref-type="bibr" rid="nijmegen.REF.gennery.2004.214">Gennery et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.new.2005.494">New et al 2005</xref>].</p>
            </fn>
            <fn id="nijmegen.TF.2.10">
              <label>10. </label>
              <p>Fanconi anemia is associated with mutation of <italic toggle="yes">BRCA2, BRIP1, ERCC4</italic>, <italic toggle="yes">FANCA</italic>, <italic toggle="yes">FANCB</italic>, <italic toggle="yes">FANCC</italic>, <italic toggle="yes">FANCD2</italic>, <italic toggle="yes">FANCE</italic>, <italic toggle="yes">FANCF</italic>, <italic toggle="yes">FANCG</italic>, <italic toggle="yes">FANCI</italic>, <italic toggle="yes">FANCL</italic>, <italic toggle="yes">FANCM</italic>, <italic toggle="yes">PALB2</italic>, <italic toggle="yes">RAD51</italic>, <italic toggle="yes">RAD51C</italic>, <italic toggle="yes">SLX4</italic>, or <italic toggle="yes">UBE2T.</italic></p>
            </fn>
            <fn id="nijmegen.TF.2.11">
              <label>11. </label>
              <p>Increased sensitivity of lymphocytes to alkylating agents like mitomycin C and/or diepoxybutane is the cellular marker of Fanconi anemia and is used as a diagnostic aid.</p>
            </fn>
            <fn id="nijmegen.TF.2.12">
              <label>12. </label>
              <p>Occasionally individuals with the <italic toggle="yes">ATM</italic> pathogenic variant A-TFresno have symptoms of both Nijmegen breakage syndrome and ataxia-telangiectasia (A-T) [<xref ref-type="bibr" rid="nijmegen.REF.curry.1989.270">Curry et al 1989</xref>, <xref ref-type="bibr" rid="nijmegen.REF.gilad.1998.551">Gilad et al 1998</xref>].</p>
            </fn>
            <fn id="nijmegen.TF.2.13">
              <label>13. </label>
              <p>
                <xref ref-type="bibr" rid="nijmegen.REF.odriscoll.2003.497">O'Driscoll et al [2003]</xref>
              </p>
            </fn>
            <fn id="nijmegen.TF.2.14">
              <label>14. </label>
              <p>See <related-object link-type="booklink" source-id="gene" document-id="microcephaly" document-type="chapter">Primary Autosomal Recessive Microcephalies and Seckel Syndrome Spectrum Disorders</related-object>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="nijmegen.Management">
        <title>Management</title>
        <sec id="nijmegen.Evaluations_Following_Initial_D">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Nijmegen breakage syndrome (NBS), the following evaluations are recommended (if they were not performed as part of the diagnostic evaluation):</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of growth</p>
            </list-item>
            <list-item>
              <p>Evaluation of immunologic status to include:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Complete blood count;</p>
                </list-item>
                <list-item>
                  <p>Absolute number of B-cells, T-cells, and T-cell subsets, with special attention to na&#x000ef;ve CD4+CD45RA cells;</p>
                </list-item>
                <list-item>
                  <p>Proliferative response of peripheral blood mononuclear cells to stimuli;</p>
                </list-item>
                <list-item>
                  <p>Concentration of total serum immunoglobulins (IgG, IgA, IgM) and IgG subclasses;</p>
                </list-item>
                <list-item>
                  <p>Evaluation for viruses with lymphotrotropic capacity (i.e., EBV and CMV).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Evaluation for malignancy, including a focused family history of other individuals with cancer</p>
            </list-item>
            <list-item>
              <p>Evaluation of the endocrinologic status in females who are of pubertal age to include pelvic ultrasound to evaluate for streak gonads and plasma levels of FSH, LH, and estrogen [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2010a.3133">Chrzanowska et al 2010a</xref>]</p>
            </list-item>
            <list-item>
              <p>Assessment of cognitive development and intellectual abilities</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="nijmegen.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Nutrition.</bold> Because of chromosome instability, vitamin E and folic acid supplementation in doses appropriate for body weight is recommended.</p>
          <p><bold>Infections.</bold> In individuals with severe humoral immunodeficiency and frequent infections, Ig replacement therapy should be considered.</p>
          <list list-type="bullet">
            <list-item>
              <p>Ig replacement is typically administered either intravenously (IVIg) or subcutaneously (SCIg).</p>
            </list-item>
            <list-item>
              <p>The spectrum of recurrent infections in NBS is not opportunistic; therefore, the antibiotic selected should be appropriate for the microorganism being treated.</p>
            </list-item>
          </list>
          <p><bold>Malignancy.</bold> Standard treatment chemotherapy protocols for lymphoid malignancies in NBS need to be adopted according to individual tolerance [<xref ref-type="bibr" rid="nijmegen.REF.dembowskabaginska.2009.186">Dembowska-Baginska et al 2009</xref>, <xref ref-type="bibr" rid="nijmegen.REF.pastorczak.2016.126">Pastorczak et al 2016</xref>]. Treatment of affected individuals with solid tumors is also challenging. Radiotherapy of CNS tumors (medulloblastoma) caused severe complications and death in three individuals with NBS [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.1997.309">Chrzanowska et al 1997</xref>, <xref ref-type="bibr" rid="nijmegen.REF.bakhshi.2003.248">Bakhshi et al 2003</xref>, <xref ref-type="bibr" rid="nijmegen.REF.distel.2003.44">Distel et al 2003</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Although complete clinical remission (for &#x0003e;5 years) can be successfully achieved, in a proportion of affected individuals outcome is complicated by relapse or the development of a second malignancy [<xref ref-type="bibr" rid="nijmegen.REF.dembowskabaginska.2009.186">Dembowska-Baginska et al 2009</xref>, <xref ref-type="bibr" rid="nijmegen.REF.bienemann.2011.468">Bienemann et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>For individuals who achieve first remission, hematopoietic stem cell transplantation (HSCT) may be considered:</p>
              <list list-type="bullet">
                <list-item>
                  <p>The first successful bone marrow transplantation was performed in an individual with NBS who was initially misdiagnosed with Fanconi anemia (FA) [<xref ref-type="bibr" rid="nijmegen.REF.gennery.2004.214">Gennery et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.gennery.2005.239">Gennery et al 2005</xref>].</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="bibr" rid="nijmegen.REF.wolskaku_nierz.2015.538">Wolska-Ku&#x0015b;nierz et al [2015]</xref> summarized the results of HSCT in 14 individuals with NBS, nine of whom were alive [<xref ref-type="bibr" rid="nijmegen.REF.gennery.2005.239">Gennery et al 2005</xref>, <xref ref-type="bibr" rid="nijmegen.REF.new.2005.494">New et al 2005</xref>, <xref ref-type="bibr" rid="nijmegen.REF.albert.2010.622">Albert et al 2010</xref>].</p>
                </list-item>
                <list-item>
                  <p><xref ref-type="bibr" rid="nijmegen.REF.wo_niak.2015.e51">Wo&#x0017a;niak et al [2015]</xref> reported the successful use of non-myeloablative umbilical cord transplantation in a child age 19 months with NBS and severe combined immune deficiency.</p>
                </list-item>
                <list-item>
                  <p>Further long-term follow up is needed to determine the outcome of HSCT in individuals with NBS.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Puberty and fertility.</bold> Females with NBS who are of pubertal age should be referred for evaluation by a gynecologist and/or endocrinologist to evaluate for hypergonadotropic hypogonadism.</p>
          <list list-type="bullet">
            <list-item>
              <p>Hormonal replacement therapy should be considered with careful monitoring of secondary sexual characteristics and uterus development.</p>
            </list-item>
            <list-item>
              <p>Females are infertile; similarly, no male paternity has been reported.</p>
            </list-item>
          </list>
        </sec>
        <sec id="nijmegen.Surveillance">
          <title>Surveillance</title>
          <p>
            <bold>Affected individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Periodic follow-up to monitor developmental progress, physical growth (including weight, length/height, and head circumference) and frequency of infections; monitoring for weight loss, which may signal the presence of a malignancy</p>
            </list-item>
            <list-item>
              <p>Lifelong monitoring of immune biomarkers to include the parameters listed in <xref ref-type="sec" rid="nijmegen.Evaluations_Following_Initial_D">Evaluations Following Initial Diagnosis</xref></p>
            </list-item>
            <list-item>
              <p>Careful follow up by oncologist: in individuals with NBS who are immunodeficient symptoms of lymphoid malignancies can be misleading.</p>
            </list-item>
            <list-item>
              <p>Monitoring for pubertal progression in both females and males and for premature ovarian insufficiency in females [<xref ref-type="bibr" rid="nijmegen.REF.chrzanowska.2010b.88">Chrzanowska et al 2010b</xref>]</p>
            </list-item>
            <list-item>
              <p>Breast self-examination and ultrasonographic evaluation recommended in affected females</p>
            </list-item>
          </list>
          <p>
            <bold>Carriers (heterozygotes)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Parents.</bold> As obligate carriers, parents should be monitored for malignancy, in particular breast cancer in women and prostate cancer in men. No consensus tumor screening protocols for carriers have been published.</p>
            </list-item>
            <list-item>
              <p><bold>At-risk sibs.</bold> Evidence of cancer risk in young carriers is insufficient to warrant screening in childhood.</p>
            </list-item>
          </list>
        </sec>
        <sec id="nijmegen.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Because the cells from individuals with NBS are as radiosensitive in vitro as those from individuals with <related-object link-type="booklink" source-id="gene" document-id="ataxia-telangiectas" document-type="chapter">ataxia-telangiectasia</related-object> (another chromosome instability syndrome), conventional doses of radiation used in radiotherapy could be lethal in individuals with NBS. Family members should be made aware of this risk so that they can discuss appropriate treatment options if a malignancy is diagnosed.</p>
          <p>Similarly, unnecessary exposure to ionizing radiation should be avoided; instead of radiograph or CT scan, MR imaging and ultrasound examination are strongly recommended.</p>
        </sec>
        <sec id="nijmegen.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to offer molecular genetic testing for the <italic toggle="yes">NBN</italic> pathogenic variants identified in the proband to apparently asymptomatic sibs of a proband and young adult relatives at risk of being carriers (heterozygotes) in order to identify as early as possible those who would benefit from monitoring for malignancy (see <xref ref-type="sec" rid="nijmegen.Surveillance">Surveillance</xref>) and to inform treatment options if a malignancy is diagnosed (see <xref ref-type="sec" rid="nijmegen.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>).</p>
          <p>See <xref ref-type="sec" rid="nijmegen.Related_Genetic_Counseling_Issu">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="nijmegen.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="nijmegen.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="nijmegen.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>NBS is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="nijmegen.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">NBN</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are asymptomatic; however, in some populations, there is evidence of increased cancer risk for heterozygotes [<xref ref-type="bibr" rid="nijmegen.REF.seemanov_.2007.1875">Seemanov&#x000e1; et al 2007</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic; however, in some populations, there is evidence of an increased cancer risk for heterozygotes [<xref ref-type="bibr" rid="nijmegen.REF.seemanov_.2007.1875">Seemanov&#x000e1; et al 2007</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> No affected individuals have been reported to reproduce.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">NBN</italic> pathogenic variant.</p>
        </sec>
        <sec id="nijmegen.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">NBN</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="nijmegen.Related_Genetic_Counseling_Issu">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="nijmegen.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="nijmegen.Prenatal_Testing_and_Preimplant">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">NBN</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for NBS are possible.</p>
        </sec>
      </sec>
      <sec id="nijmegen.Resources">
        <title>Resources</title>
      </sec>
      <sec id="nijmegen.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">NBN</italic> is encoded in 16 exons and spans approximately 51 kb of DNA. The entire gene has been sequenced. The gene encodes two transcripts of 4.6 kb (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002485.4">NM_002485.4</ext-link>) and 2.4 kb [<xref ref-type="bibr" rid="nijmegen.REF.carney.1998.477">Carney et al 1998</xref>] that are expressed in all tissues examined and differ only in their site of polyadenylation. Transcript <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002485.4">NM_002485.4</ext-link> has 16 exons and encodes a protein of 754 amino acids. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="nijmegen" object-id="nijmegen.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Most disease-causing <italic toggle="yes">NBN</italic> alleles identified to date are predicted to result in truncation of the nibrin protein (see <xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">Table 3</xref>). The c.657_661del5 pathogenic variant is most common, accounting for the majority of all disease alleles in <italic toggle="yes">NBN</italic>. Other pathogenic variants (<xref ref-type="table" rid="nijmegen.T.selected_nbn_pathogenic_varia">Table 3</xref>) occur in one or a small number of families. <italic toggle="yes">NBN</italic> mRNA is always detectable in cell lines from individuals with NBS, but full-length nibrin protein is not detectable by western blotting.</p>
        <p>One pathogenic variant, p.Tyr363Ter, was detected homozygous in an individual diagnosed with atypical <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia</related-object>, as well as several affected family members with similar clinical features [<xref ref-type="bibr" rid="nijmegen.REF.gennery.2004.214">Gennery et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.new.2005.494">New et al 2005</xref>]. These findings highlight the lack of disease specificity in assays that test for sensitivity to DNA crosslinking agents.</p>
        <p>While the overwhelming majority of persons with NBS have <italic toggle="yes">NBN</italic> biallelic truncating alleles, <xref ref-type="bibr" rid="nijmegen.REF.seemanov_.2006.218">Seemanov&#x000e1; et al [2006]</xref> have described a unique set of monozygotic twins who are compound heterozygous for the common c.657_661del5 pathogenic variant and a missense variant, c.643C&#x0003e;T resulting in p.Arg215Trp. These twins had a more severe clinical course than typical for NBS (particularly with respect to neurologic features) but lacked the cellular chromosome instability and radiation sensitivity characteristic of the disorder.</p>
        <table-wrap id="nijmegen.T.selected_nbn_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">NBN</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
                <th id="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Origin</th>
                <th id="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Number of Families in Whom Pathogenic Variant is Observed</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.330T&#x0003e;G</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr110Ter</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_3" rowspan="13" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_002485.4">NM_002485.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_002476.2">NP_002476.2</ext-link>
                </td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.643C&#x0003e;T</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg215Trp</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Slavic</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.657_661del5<break/>(657del5)</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys219AsnfsTer15</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Slavic</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">N/A</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.681delT</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe227LeufsTer4</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Russian</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.698_701del4</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys233SerfsTer4</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">English</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.741_742dup<break/>(742insGG)</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu248GlyfsTer5</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Italian</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.835_838del4</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln279ProfsTer1</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Italian</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.842insT</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu281PhefsTer3</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Mexican</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.900del25</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly301LysfsTer5</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Moroccan</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.976C&#x0003e;T</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln326Ter</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Dutch</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1089C&#x0003e;A</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr363Ter</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Pakistani&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">3</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1125G&#x0003e;A</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp375Ter</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1"/>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">1</td>
              </tr>
              <tr>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1142delC</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro381GlnfsTer22</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_4" valign="middle" colspan="1" align="left" rowspan="1">Canadian</td>
                <td headers="hd_h_nijmegen.T.selected_nbn_pathogenic_varia_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">2</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="nijmegen.TF.3.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="nijmegen.TF.3.2">
              <label>2. </label>
              <p>Individual originally diagnosed as having <related-object link-type="booklink" source-id="gene" document-id="fa" document-type="chapter">Fanconi anemia</related-object> with atypical clinical features. See <xref ref-type="sec" rid="nijmegen.Differential_Diagnosis">Differential Diagnosis</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The <italic toggle="yes">NBN</italic> protein product is nibrin, also known as p95. Nibrin is a protein of 85 kd in mass that is ubiquitously expressed. There is no sequence homology between nibrin and other known proteins. However, nibrin contains a forkhead-associated domain and two breast cancer carboxy-terminal domains, which are involved in cellular responses to DNA damage. In normal fibroblasts, nibrin is associated with two other proteins involved in DNA repair, hMre11 and hRad50. On exposure to ionizing radiation, this complex of proteins, including nibrin, forms nuclear foci at sites where DNA repair has taken place. Nibrin targets the <italic toggle="yes">NBN</italic>/Mre11/Rad50 complex to sites of double-strand breaks and interacts with ATM kinase to coordinate cell cycle arrest with DNA repair [<xref ref-type="bibr" rid="nijmegen.REF.carney.1998.477">Carney et al 1998</xref>, <xref ref-type="bibr" rid="nijmegen.REF.matsuura.2004.65">Matsuura et al 2004</xref>, <xref ref-type="bibr" rid="nijmegen.REF.falck.2005.605">Falck et al 2005</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Most known <italic toggle="yes">NBN</italic> pathogenic variants are predicted to result in truncation of the nibrin protein (often termed p70). All known NBS pathogenic variants occur in exons 6-10; presumably reflecting a requirement for production of a C-terminal protein fragment of nibrin that occurs by translational re-initiation mechanism [<xref ref-type="bibr" rid="nijmegen.REF.maser.2001.417">Maser et al 2001</xref>]. The requirement that protein termination and re-initiation occur in the same reading frame potentially limits the pathogenic variants that can give rise to NBS. Knockout mice homozygous for null alleles of <italic toggle="yes">NBN</italic> are embryonic lethal, suggesting that the partial protein produced from <italic toggle="yes">NBN</italic> alleles in humans is necessary for survival.</p>
      </sec>
      <sec id="nijmegen.References">
        <title>References</title>
        <sec id="nijmegen.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="nijmegen.Literature_Cited.reflist0">
            <ref id="nijmegen.REF.albert.2010.622">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greil</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cale</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalwak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondratenko</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarski</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notheis</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000fc;hrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmid</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>Successful SCT for Nijjmegen breakage syndrome.</article-title>
                <source>Bone Marrow Transplantation</source>
                <year>2010</year>
                <volume>45</volume>
                <fpage>622</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19684627</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.altmann.2016.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Altmann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>DNA ligase IV syndrome; a review.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2016</year>
                <month>Oct</month>
                <day>7</day>
                <volume>11</volume>
                <issue>1</issue>
                <fpage>137</fpage>
                <pub-id pub-id-type="pmid">27717373</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.bakhshi.2003.248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bakhshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerosaletti</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bawle</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontanesi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhambhani</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome.</article-title>
                <source>J Pediatr Hematol Oncol</source>
                <volume>25</volume>
                <fpage>248</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">12621246</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.barbi.1991.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barbi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheres</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taalman</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodens</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehnert</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seyschab</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child.</article-title>
                <source>Am J Med Genet.</source>
                <year>1991</year>
                <volume>40</volume>
                <fpage>44</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">1887849</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.benomran.2005.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>TI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerosaletti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weitzman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nezarati</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>A patient with mutations in NDA ligase IV: clinical features and overlap with Nijmegen breakage syndrome.</article-title>
                <source>Am J Med Genet</source>
                <year>2005</year>
                <volume>137A</volume>
                <fpage>283</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16088910</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.bienemann.2011.468">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bienemann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burkhardt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modlich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f6;ricke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bienemann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mauz-K&#x000f6;rholz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escherich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;rholz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janka-Schaub</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrappe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borkhardt</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.</article-title>
                <source>Br J Haematol.</source>
                <year>2011</year>
                <volume>155</volume>
                <fpage>468</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">21923652</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.carney.1998.477">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carney</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maser</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivares</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Beau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JR</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrini</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.</article-title>
                <source>Cell</source>
                <volume>93</volume>
                <fpage>477</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">9590181</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.chrzanowska.1997.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bialecka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernatowska-Matuszkiewicz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalkiewicz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barszcz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wegner</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <article-title>Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient.</article-title>
                <source>Clin Genet</source>
                <year>1997</year>
                <volume>51</volume>
                <fpage>309</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">9212178</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.chrzanowska.2012.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dembowska-Bagi&#x00144;ska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalina</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Nijmegen breakage syndrome (NBS).</article-title>
                <source>Orphanet J Rare Dis.</source>
                <volume>7</volume>
                <fpage>13</fpage>
                <pub-id pub-id-type="pmid">22373003</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.chrzanowska.2000.s73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gajtko-Metera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szarras-Czapnik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramezuk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rysiewski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Evidence for a high rate of gonadal failure in female patients with Nijmegen breakage syndrome.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2000</year>
                <volume>8</volume>
                <fpage>S73</fpage>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.chrzanowska.2010a.3133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szarras-Czapnik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gajdulewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalina</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gajtko-Metera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walewska-Wolf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szufladowicz-Wozniak</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rysiewski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cukrowska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piekutowska-Abramczuk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010a</year>
                <article-title>High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <volume>95</volume>
                <fpage>3133</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20444919</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.chrzanowska.2010b.88">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szarras-Czapnik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gajdulewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gajtko-Metera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rysiewski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dembowska-Bagi&#x00144;ska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piekutowska-Abramczuk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010b</year>
                <article-title>Gonadal function in male patients with Nijmegen breakage syndrome, a cancer-prone disease with the DNA repair defect.</article-title>
                <comment>Abstract</comment>
                <source>Eur J Hum Genet</source>
                <volume>18</volume>
                <supplement>Suppl 1</supplement>
                <fpage>88</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19584901</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.ciara.2010.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ciara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piekutowska-Abramczuk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Popowska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grajkowska</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barszcz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dembowska-Bagi&#x00144;ska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perek-Polnik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kowalewska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czaj&#x00144;ska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czornak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewska-Walasek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roszkowski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.</article-title>
                <source>Acta Neuropathol.</source>
                <volume>119</volume>
                <fpage>325</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19908051</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.curry.1989.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Lague</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchison</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>45</volume>
                <fpage>270</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2491181</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.cybulski.2004.1215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cybulski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorski</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debniak</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gliniewicz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mierzejewski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masojc</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakubowska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matyjasik</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zlowocka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sikorski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narod</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubinski</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>NBS1 is a prostate cancer susceptibility gene.</article-title>
                <source>Cancer Res</source>
                <volume>64</volume>
                <fpage>1215</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14973119</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.dembowskabaginska.2009.186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dembowska-Baginska</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brozyna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakulinska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olczak-Kowalczyk</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gladkowska-Dura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grajkowska</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <article-title>Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).</article-title>
                <source>Pediatr Blood Cancer.</source>
                <year>2009</year>
                <volume>52</volume>
                <fpage>186</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">18937313</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.distel.2003.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Distel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabenbauer</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome</article-title>
                <source>Med Pediatr Oncol</source>
                <volume>41</volume>
                <fpage>44</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12764742</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.dutrannoy.2010.1059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dutrannoy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demuth</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konrat</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kaesbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radszewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellenberger</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teik</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nallusamy</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>1059</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">20597108</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.falck.2005.605">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Falck</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coates</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.</article-title>
                <source>Nature.</source>
                <volume>434</volume>
                <fpage>605</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">15758953</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.gennery.2004.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slatter</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barge</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haigh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flood</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeggo</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.</article-title>
                <source>Clin Immunol</source>
                <volume>113</volume>
                <fpage>214</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15451479</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.gennery.2005.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slatter</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeggo</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flood</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <article-title>Bone marrow transplantation for Nijmegen breakage syndrome.</article-title>
                <source>J Pediatr Hematol Oncol</source>
                <year>2005</year>
                <volume>27</volume>
                <fpage>239</fpage>
                <pub-id pub-id-type="pmid">15838402</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.gilad.1998.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gilad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chessa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khosravi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galanty</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorgensen</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiloh</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Shira</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Genotype-phenotype relationships in ataxia-telangiectasia and variants.</article-title>
                <source>Am J Hum Genet</source>
                <volume>62</volume>
                <fpage>551</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9497252</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.g_adkowskadura.2008.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x00142;adkowska-Dura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dzierzanowska-Fangrat</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dura</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Krieken</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dongen</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langerak</surname>
                    <given-names>AW</given-names>
                  </name>
                </person-group>
                <article-title>Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation.</article-title>
                <source>J Pathol.</source>
                <year>2008</year>
                <volume>216</volume>
                <fpage>337</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">18788073</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.gregorek.2002.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalkiewicz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madalinski</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre.</article-title>
                <source>Clin Exp Immunol.</source>
                <year>2002</year>
                <volume>130</volume>
                <fpage>319</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12390322</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.hiel.2001.e19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hiel</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weemaes</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligtenberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Der Burgt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerosaletti</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabre&#x000eb;ls</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Nijmegen breakage syndrome in a Dutch patient not resulting from a defect in NBS1.</article-title>
                <source>J Med Genet.</source>
                <year>2001</year>
                <volume>38</volume>
                <fpage>E19</fpage>
                <pub-id pub-id-type="pmid">11389166</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.jaspers.1988.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jaspers</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bootsma</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients.</article-title>
                <source>Cytogenet Cell Genet</source>
                <volume>49</volume>
                <fpage>259</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">3248383</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.maraschio.1986.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maraschio</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peretti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambiase</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo Curto</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caufin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gargantini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minoli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>New chromosome instability disorder.</article-title>
                <source>Clin Genet.</source>
                <year>1986</year>
                <volume>30</volume>
                <fpage>353</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">3802554</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.maser.2001.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maser</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinkel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrini</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele.</article-title>
                <source>Nat Genet</source>
                <volume>27</volume>
                <fpage>417</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11279524</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.matsuura.2004.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tauchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komatsu</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex.</article-title>
                <source>Adv Biophys.</source>
                <year>2004</year>
                <volume>38</volume>
                <fpage>65</fpage>
                <lpage>80</lpage>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.maurer.2010.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maurer</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.</article-title>
                <source>J Appl Genet.</source>
                <volume>51</volume>
                <fpage>211</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20453309</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.meyer.2004.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingston</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrd</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Last</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brennan</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trueman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eden</surname>
                    <given-names>OB</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Rhabdomyosarcoma in Nijmegen breakage syndrome: strong association with perianal primary site.</article-title>
                <source>Cancer Genet Cytogenet</source>
                <volume>154</volume>
                <fpage>169</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">15474156</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.micha_kiewicz.2003.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Micha&#x00142;kiewicz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weemaes</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madali&#x00144;ski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stachowski</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.</article-title>
                <source>Clin Exp Immunol.</source>
                <year>2003</year>
                <month>Dec</month>
                <volume>134</volume>
                <issue>3</issue>
                <fpage>482</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">14632755</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.murray.2015.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Burg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>IJspeert</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leitch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kysela</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jawad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bottani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deshpande</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faqeih</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranza</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blundell</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bicknell</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the NHEJ component XRCC4 cause primordial dwarfism.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>96</volume>
                <fpage>412</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">25728776</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.new.2005.494">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>New</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cale</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tischkowitz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Telfer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veys</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Andrea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathew</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hann</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Nijmegen breakage syndrome diagnosed as Fanconi anaemia.</article-title>
                <source>Pediatr Blood Cancer</source>
                <volume>44</volume>
                <fpage>494</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15593232</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.odriscoll.2001.1175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerosaletti</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girard</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kysela</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oettinger</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeggo</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency.</article-title>
                <source>Mol Cell</source>
                <volume>8</volume>
                <fpage>1175</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">11779494</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.odriscoll.2003.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Perez</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeggo</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodship</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>497</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">12640452</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.pasic.2012.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kandolf-Sekulovic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djuricic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zolotarevski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simic</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Necrobiotic cutaneous granulomas in Nijmegen breakage syndrome.</article-title>
                <source>J Investig Allergol Clin Immunol.</source>
                <year>2012</year>
                <volume>22</volume>
                <issue>2</issue>
                <fpage>138</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">22533239</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.pastorczak.2016.126">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pastorczak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczepanski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mlynarski</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2016</year>
                <volume>59</volume>
                <fpage>126</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">26826318</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.resnick.2002.355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Resnick</surname>
                    <given-names>IB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondratenko</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Togoev</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasserman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shagina</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tverskaya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cerosaletti</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatti</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concannon</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families.</article-title>
                <source>J Pediatr.</source>
                <volume>140</volume>
                <fpage>355</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">11953735</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.rosin.2015.3708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elcioglu</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beleggia</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isg&#x000fc;ven</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altm&#x000fc;ller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steindl</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joset</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Wollnik B8, Yigit G1. Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2015</year>
                <volume>24</volume>
                <fpage>3708</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">25839420</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.seeman.2004.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gebertova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paderova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly.</article-title>
                <source>Pediatr Neurol</source>
                <volume>30</volume>
                <fpage>195</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">15033202</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.seemanov_.2007.1875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seemanov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jarolim</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Cancer risk of heterozygotes with the NBN founder mutation.</article-title>
                <source>J Natl Cancer Inst.</source>
                <year>2007</year>
                <month>Dec</month>
                <day>19</day>
                <volume>99</volume>
                <issue>24</issue>
                <fpage>1875</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18073374</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.seemanov_.1985.639">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seemanov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passarge</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beneskova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houstek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevcikova</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Familial microcephaly with normal intelligence, immunodeficiency, and risk for lymphoreticular malignancies: a new autosomal recessive disorder.</article-title>
                <source>Am J Med Genet</source>
                <volume>20</volume>
                <fpage>639</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">3857858</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.seemanov_.2006.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seemanov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadac</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butova</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;ck</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability.</article-title>
                <source>J Med Genet.</source>
                <year>2006</year>
                <volume>43</volume>
                <fpage>218</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">16033915</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.steffen.2004.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steffen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mosor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maneva</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowakowska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosakowska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruka</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowecki</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutkowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demkow</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bidzinski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gawrychowski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland.</article-title>
                <source>Int J Cancer</source>
                <volume>111</volume>
                <fpage>67</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15185344</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.varon.2006.679">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dutrannoy</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weikert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanzarella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antoccia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ckl</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kr&#x000fc;ger</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>di Masi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maraschio</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mild Nijmegen breakage syndrome phenotype due to alternative splicing.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>15</volume>
                <fpage>679</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">16415040</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.waltes.2009.605">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waltes</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalb</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gatei</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kijas</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobeck</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieland</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerenthal</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavin</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dork</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2009</year>
                <volume>84</volume>
                <fpage>605</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">19409520</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.warcoin.2009.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warcoin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lespinasse</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Despouy</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois d'Enghien</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laug&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portno&#x000ef;</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christin-Maitre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoppa-Lyonnet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Fertility defects revealing germline biallelic nonsense NBN mutations.</article-title>
                <source>Hum Mutat.</source>
                <volume>30</volume>
                <fpage>424</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">19105185</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.weemaes.1981.557">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weemaes</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hustinx</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheres</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Munster</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakkeren</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taalman</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <year>1981</year>
                <article-title>A new chromosomal instability disorder: the Nijmegen breakage syndrome.</article-title>
                <source>Acta Paediatr Scand</source>
                <volume>70</volume>
                <fpage>557</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">7315300</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.wegner.1999">
              <mixed-citation publication-type="book">Wegner RD, Chrzanowska KH, Sperling K, Stumm M. Ataxia-telangiectasia variants (Nijmegen breakage syndrome). In: Ochs HD, Smith CIE, Puck JM, eds. <italic toggle="yes">Primary Immunodeficiency Diseases, a Molecular and Genetic Approach.</italic> Oxford, UK: Oxford University Press; 1999:324-34</mixed-citation>
            </ref>
            <ref id="nijmegen.REF.wolskaku_nierz.2015.538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wolska-Ku&#x0015b;nierz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregorek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chrzanowska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pi&#x00105;tosa</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrucha</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heropolita&#x00144;ska-Pliszka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pac</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klaudel-Dreszler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostyuchenko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marodi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x0010c;i&#x0017e;n&#x000e1;r</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shcherbina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidel</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syczewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miko&#x00142;u&#x00107;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ka&#x00142;wak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Styczy&#x00144;ski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieczonka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drabko</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakuli&#x00144;ska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gathmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albert</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skar&#x0017c;y&#x00144;ska</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernatowska</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Nijmegen breakage syndrome: clinical and immunological features, long-term outcome and treatment options - a retrospective analysis.</article-title>
                <source>J Clin Immunol.</source>
                <year>2015</year>
                <volume>35</volume>
                <fpage>538</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">26271390</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.wo_niak.2015.e51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wo&#x0017a;niak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krzywo&#x00144;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho&#x00142;da</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Go&#x0017a;dzik</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Reduced-intensity conditioning umbilical cord blood transplantation in Nijmegen breakage syndrome.</article-title>
                <source>Pediatr Transplant.</source>
                <year>2015</year>
                <volume>19</volume>
                <fpage>E51</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25523867</pub-id>
              </element-citation>
            </ref>
            <ref id="nijmegen.REF.yoo.2008.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolgamot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torgerson</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidbury</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Cutaneous noncaseating granulomas associated with Nijmegen breakage syndrome.</article-title>
                <source>Arch Dermatol.</source>
                <year>2008</year>
                <volume>144</volume>
                <fpage>418</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18347309</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="nijmegen.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="nijmegen.Suggested_Reading.reflist0">
            <ref id="nijmegen.REF.demuth.2007.7792">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demuth</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Digweed</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.</article-title>
                <source>Oncogene</source>
                <volume>26</volume>
                <fpage>7792</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18066092</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="nijmegen.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="nijmegen.Author_History">
          <title>Author History</title>
          <p>Krystyna H Chrzanowska, MD, PhD (2017-present) Patrick Concannon, PhD; University of Florida Genetics Institute (1999-2014)Ilja Demuth, PhD (2014-present)Martin Digweed, PhD; Universit&#x000e4;tsmedizin Berlin (2014-2017)Richard Gatti, MD; University of California Los Angeles (1999-2014)Raymonda Varon, PhD (2014-present)</p>
        </sec>
        <sec id="nijmegen.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>2 February 2017 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 May 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>1 March 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 June 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 March 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>17 May 1999 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 January 1999 (pc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
